Evaluation of a pharmacist-managed anticoagulation clinic: Improving patient care

Open Medicine

Volumn 3, Issue 1, 2009, Pages 16-21

  Bungard, Tammy J ^a   Gardner, Leslie ^b   Archer, Stephen L ^c   Hamilton, Peter ^a   Ritchie, Bruce ^a   Tymchak, Wayne ^a   Tsuyuki, Ross T ^a,d  

^a UNIVERSITY OF ALBERTA   (Canada)

^b University of Chicago ^*

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 65549121562     PISSN: None     EISSN: 19112092     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 Suppl):S204-S233.
2. Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med. 1994;120(11):897-902.
3. Hylek EM, Skates SJ, Sheehan MA, Singer DE. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med. 1996;335(8):540-546.
4. Bungard TJ, Ghali WA, Teo KK, McAlister FA, Tsuyuki RT. Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med. 2000;160:41-46.
5. Tsuyuki RT, Walters B, Yim R, Teo KK. Re: The Clinical Quality Improvement Network (CQIN) Investigators. Thromboembolic prophylaxis in 3,575 hospitalized patients with atrial fibrillation. 1998;14:695-702. Can J Cardiol. 2000;16(1):99.
6. Bungard TJ, Ackman ML, Ho G, Tsuyuki RT. Adequacy of anticoagulation in patients with atrial fibrillation coming to a hospital. Pharmacotherapy. 2000;20(9):1060-1065.
7. Burkiewicz JS. Effect of access to anticoagulation management services on warfarin use in patients with atrial fibrillation. Pharmacotherapy. 2005;25(8):1062-1067.
8. Charney R, Leddomado E, Rose DN, Fuster V. Anticoagulation clinics and the monitoring of anticoagulant therapy. Int J Cardiol. 1988;18(2):197-206.
9. Conte RR, Kehoe WA, Nielson N, Lodhia H. Nine-year experience with a pharmacist-managed anticoagulation clinic. Am J Hosp Pharm. 1986;43(10):2460-2464.
10. Davis FB, Estruch MT, Samson-Corvera EB, Voigt GC, Tobin JD. Management of anticoagulation in outpatients: experience with an anticoagulation service in a municipal hospital setting. Arch Intern Med. 1977;137(2):197-202.
11. Errichetti AM, Holden A, Ansell J. Management of oral anticoagulant therapy. Experience with an anticoagulation clinic. Arch Intern Med. 1984;144(10):1966-1968.
12. Seabrook GR, Karp D, Schmitt DD, Bandyk DF, Towne JB. An outpatient anticoagulation protocol managed by a vascular nurse-clinician. Am J Surg. 1990;160(5):501-505.
13. Bungard TJ, Archer SL, Hamilton P, Ritchie B, Tymchak W, Tsuyuki RT. Bringing the benefits of anticoagulation management services to the community: Alberta program may serve as a model of care. Can Pharm J. 2006;139(2):58-63.
14. Rosendaal FR, Cannegieter SC, van der Meer FJ, Briët E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993;69(3):236-239.
15. Hicks V, Fortin G, Ballinger G. Price indexes used in national health expenditures: feasibility study. Ottawa: Canadian Institute for Health Information: 2007.
16. Ansell JE, Hughes R. Evolving models of warfarin management: anticoagulation clinics, patient self-monitoring, and patient self-management. Am Heart J. 1996;132(5):1095-1100.